Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioCardia

1.51
+0.170012.69%
Post-market: 1.48-0.0300-1.99%19:56 EDT
Volume:841.67K
Turnover:1.24M
Market Cap:16.02M
PE:-0.73
High:1.57
Open:1.34
Low:1.33
Close:1.34
52wk High:3.20
52wk Low:1.00
Shares:10.61M
Float Shares:4.05M
Volume Ratio:3.33
T/O Rate:20.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0546
EPS(LYR):-2.8960
ROE:-737.89%
ROA:-222.28%
PB:-8.49
PE(LYR):-0.52

Loading ...

BioCardia Sets Record Date for Annual Meeting

TIPRANKS
·
Oct 08

BioCardia Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire
·
Oct 02

IPS, Inc. Partners with BCDA to Boost Luzon Island’s Digital Infrastructure

TIPRANKS
·
Sep 30

BioCardia Inc. Granted Nasdaq Extension After Falling Below Stockholders’ Equity Listing Requirement

Reuters
·
Sep 24

BioCardia Executives Make Bold Moves with Major Stock Purchases

TIPRANKS
·
Sep 24

Analysts Conflicted on These Healthcare Names: Alector (ALEC), Nurix Therapeutics (NRIX) and BioCardia (BCDA)

TIPRANKS
·
Sep 24

BioCardia Inc. CEO Peter Altman Reports Acquisition of Common Shares

Reuters
·
Sep 24

BioCardia Inc. Raises $5.1 Million Through Sale of Common Stock and Warrants in Recent Offering

Reuters
·
Sep 23

BioCardia Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 23

BioCardia’s Positive Consultation with Japan’s PMDA

TIPRANKS
·
Sep 22

BioCardia: Completing Responses to Japan's Pmda's Questions & Anticipates Formal Clinical Consultation Near End of Year

THOMSON REUTERS
·
Sep 22

BioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart Failure

GlobeNewswire
·
Sep 22

Insiders' US$1.06m Investments In Red Following BioCardia's US$117k Dip In Market Value

Simply Wall St.
·
Sep 20

BioCardia Raises $5.1 Million Through Stock Sale

TIPRANKS
·
Sep 20

Gold Falls Over 1%; Darden Posts Downbeat Earnings

Benzinga
·
Sep 19

BioCardia Announces $6 Million Public Offering

TIPRANKS
·
Sep 18

BioCardia Announces Pricing of up to $12 Million Public Offering

THOMSON REUTERS
·
Sep 18

Press Release: BioCardia Announces Pricing of Up To $12 Million Public Offering

Dow Jones
·
Sep 18

BioCardia announces CardiAMP Cell Therapy results

TIPRANKS
·
Sep 18

BioCardia: Cardiamp Chronic Myocardial Ischemia Trial Top Line Data of Roll-in Cohort Show Improved Exercise Tolerance

THOMSON REUTERS
·
Sep 18